Industry Overview                                                

Infusion therapy devices market valued at $23,402.1 million in 2025 and is projected to reach $46,979.3 million by 2035, growing at a CAGR of 7.3% during the forecast period (2026-2035). The global infusion therapy devices market is advancing steadily as healthcare systems intensify their focus on precise, controlled, and continuous drug delivery across a wide range of clinical settings. Growth is being reinforced by the increasing prevalence of chronic diseases requiring long-term intravenous therapies, including oncology, diabetes, and autoimmune disorders. Rising adoption of smart infusion pumps, integrated monitoring systems, and digital dose-control technologies is enhancing treatment accuracy and patient safety. Demand is further supported by the expansion of home healthcare services and ambulatory care, where portable and user-friendly infusion devices play a critical role. As regulatory bodies emphasize medication safety and error reduction, advanced infusion technologies are becoming indispensable in modern healthcare delivery.

Market Dynamics

Rising Prevalence of Chronic Diseases and Demand for Long-Term Therapies

Healthcare providers are witnessing a growing need for infusion therapy devices as chronic conditions such as cancer, diabetes, and cardiovascular diseases require continuous and controlled drug administration. Hospitals and outpatient centers are increasingly relying on infusion pumps and related systems to ensure accurate dosing and improved therapeutic outcomes. The shift toward patient-centric care is also encouraging the adoption of portable infusion devices that enable treatment beyond traditional clinical environments. As patient volumes increase globally, the demand for efficient, reliable, and scalable infusion systems continues to strengthen, positioning this factor as a major driver of market growth.

Growing Integration of Smart Technologies and Automation in Infusion Systems

Technological advancements are transforming infusion therapy devices through the integration of smart features such as dose error reduction systems (DERS), wireless connectivity, and real-time monitoring capabilities. Manufacturers are focusing on developing programmable and interoperable infusion pumps that can seamlessly integrate with hospital information systems and electronic health records. Automation in infusion delivery is helping reduce manual errors, enhance workflow efficiency, and improve patient safety. As healthcare facilities prioritize digital transformation and precision medicine, the adoption of intelligent infusion systems is emerging as a key growth catalyst for the global market.

Expansion of Home Healthcare and Ambulatory Care Settings

The increasing shift toward decentralized healthcare delivery is driving the demand for infusion therapy devices in home care and ambulatory settings. Patients requiring long-term treatments, such as chemotherapy, parenteral nutrition, and pain management, are increasingly opting for home-based infusion therapies due to convenience and cost-effectiveness. This trend is encouraging manufacturers to develop compact, portable, and easy-to-use devices tailored for non-clinical environments. As healthcare systems aim to reduce hospital stays and optimize resource utilization, the role of infusion therapy devices in home healthcare continues to expand significantly.

Market Segmentation

• Based on the product type, the market is segmented into infusion pumps, and consumables and accessories.
• based on the application, the market is segmented into oncology, diabetes, gastroenterology, analgesia, hematology, and others.
• based on the end-user, the market is segmented into hospitals, homecare, and ambulatory surgery centers.

Infusion Pumps Segment to Dominate the Market with the Largest Share

In the global infusion therapy devices market, the infusion pumps segment is expected to account for the largest market share, driven by the increasing demand for precise, controlled, and continuous drug delivery across various clinical settings. Infusion pumps are widely used for administering medications, fluids, and nutrients with high accuracy, making them essential in critical care, chronic disease management, and surgical procedures. Technological advancements such as smart pumps, integration with electronic health records, and enhanced safety features are further improving efficiency and reducing medication errors. Additionally, the rising prevalence of chronic diseases and the growing need for long-term therapies are significantly boosting demand for infusion pumps, reinforcing their leading position in the market.

Oncology Segment: A Key Contributor to Market Growth

The oncology segment plays a significant role in driving growth within the infusion therapy devices market, owing to the increasing global burden of cancer and the widespread use of infusion-based chemotherapy treatments. Infusion devices are critical for delivering chemotherapeutic agents, targeted therapies, and supportive care medications with precision and consistency. The growing adoption of outpatient and home-based cancer care, along with advancements in ambulatory infusion pumps, is further supporting segment expansion. Moreover, continuous innovation in drug delivery systems and increasing healthcare investments are enhancing treatment outcomes and patient convenience. These factors collectively position the oncology segment as a major contributor to overall market growth.

Regional Outlook

The global infusion therapy devices market is further divided by geography, including North America (the US and Canada), Europe (the UK, Germany, France, Italy, Spain, Russia, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, Australia and New Zealand, ASEAN Countries, and the Rest of Asia-Pacific), and the Rest of the World (the Middle East & Africa, and Latin America).

Asia-Pacific Emerging as a High-Growth Region

Asia-Pacific is witnessing rapid expansion in the infusion therapy devices market, driven by improving healthcare infrastructure, rising patient population, and increasing awareness of advanced treatment options. Governments and private healthcare providers are investing in modern medical technologies to enhance care delivery and patient outcomes. The growing burden of chronic diseases and expanding access to healthcare services are further fueling demand for infusion systems. Additionally, the rise of home healthcare and medical tourism in the region is supporting the adoption of cost-effective and portable infusion devices.

North America Region Dominates the Market with Major Share

North America maintains a leading position in the infusion therapy devices market due to its advanced healthcare infrastructure and high adoption of technologically sophisticated medical devices. The region benefits from strong investment in healthcare innovation and widespread implementation of smart infusion systems across hospitals and specialty clinics. Increasing prevalence of chronic diseases and a well-established reimbursement framework further support market growth. Additionally, regulatory emphasis on patient safety and medication accuracy is accelerating the adoption of advanced infusion technologies. These factors collectively reinforce North America’s dominant market presence.

Market Players Outlook

The major companies operating in the global infusion therapy devices market includes B. Braun Melsungen SE, Baxter International Inc., Becton, Dickinson and Company, Fresenius Kabi AG, ICU Medical, Inc., among others. Market players are leveraging partnerships, collaborations, mergers and acquisition strategies for business expansion and innovative product development to maintain their market positioning.

Recent Developments

• In July 2025, Becton, Dickinson and Company introduced an advanced smart infusion pump platform integrated with real-time data analytics and safety alerts, aimed at reducing medication errors and improving clinical workflow efficiency.
• In May 2025, Baxter International Inc. expanded its portfolio of portable infusion pumps designed for home healthcare settings, focusing on ease of use and enhanced patient mobility for long-term therapy management.

The Report Covers

• Market value data analysis of 2025 and forecast to 2035.
• Annualized market revenues ($ million) for each market segment.
• Country-wise analysis of major geographical regions.
• Key companies operating in the global infusion therapy devices Based on the availability of data, information related to new products and relevant news is also available in the report.
• Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
• Analysis of market-entry and market expansion strategies.
• Competitive strategies by identifying ‘who-stands-where’ in the market.